AlphaStocks
6.9
Consider Buy

ILLUMINA, INC. (ILMN)

Health Care / Life Sciences Tools & Services

S&P MidCap 400

$188.59

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

#87out of 1121 in Health Care

Is ILLUMINA, INC. a Good Investment in 2026?

ILLUMINA, INC. (ILMN) scores 6.9 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates ILLUMINA, INC. as Strong (7/9). However, the Greenblatt Magic Formula model rates it Caution — Top half (rank 37%). ILLUMINA, INC. currently trades above its estimated fair value of $144, suggesting limited upside at current prices. ILLUMINA, INC. ranks #87 out of 1121 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E34.6ROE10.9Market Cap29B

Estimated Fair Value

$144.1231% above

Trading above estimated fair value. Eps growth of -41% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

PEG 1.4 · Fast Grower

Greenblatt

Caution

Top half (rank 37%)

Frequently Asked Questions

Is ILLUMINA, INC. (ILMN) a good investment?
Based on AlphaStocks' composite analysis, ILLUMINA, INC. (ILMN) scores 6.9 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trading above estimated fair value. Eps growth of -41% may not justify the premium.
What is ILLUMINA, INC.'s Piotroski F-Score?
ILLUMINA, INC.'s Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ILMN overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $144, ILMN appears overvalued. The stock currently trades 31% above its estimated fair value. Trading above estimated fair value. Eps growth of -41% may not justify the premium.
How does ILMN compare to other Health Care stocks?
ILLUMINA, INC. ranks #87 out of 1121 stocks in the Health Care sector, placing it in the top 8% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about ILMN?
AlphaStocks evaluates ILMN using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 6.9/10.

Similar Stocks

PARRBFAMAZN

Compare ILMN with

ILMN vs PARRILMN vs BFAMILMN vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer